Skip to main content

X'PROCHEM

Established in 2012, X’PROCHEM is a Contract Research Organization (CRO) specializing in protein synthesis through chemical methods.
We design and manufacture therapeutic proteins for our pharmaceutical and biotechnological partners. Leveraging an automated process, we produce complex and highly customized proteins, reaching up to 400 amino acids (40 kDa).

Mission

Develop and accelerate your projects for the production of therapeutic proteins and vaccines.

Vision

Enhance the purity and safety of today’s and tomorrow’s biopharmaceutical products.

Values

  • Expertise : Our expertise in protein synthesis, cultivated over 20 years, enables us to meet the challenges of design and production for your therapeutic proteins.

  • Client first : We listen to your needs to collaboratively build therapeutic proteins which enhance human health.
  • Reliability : Over the past 11 years, X’PROCHEM has dedicated itself to the successful completion of all entrusted projects.

  • Responsiveness: In pharmaceutical projects, changes are frequent, and some are unforeseeable. We adapt to your needs and any changes you may encounter.

History

  • Establishment of X’PROCHEM
  • i-lab Award
  • First Prize in Nord-Pas-De-Calais
  • Inaugural Generation of the X’PROCHEM Production Process

Second Generation of the X’PROCHEM Production Process

Capital Increase through Business Angels, Public Funds, and Private Funds

Collaboration with Eurasanté

Portfolio for the Co-development of Innovative Protein-based Medications

Relocation to New Facilities